Hokuyaku Takeyama HoldingsInc Past Earnings Performance
Past criteria checks 2/6
Hokuyaku Takeyama HoldingsInc has been growing earnings at an average annual rate of 4.7%, while the Healthcare industry saw earnings growing at 6% annually. Revenues have been growing at an average rate of 2.7% per year. Hokuyaku Takeyama HoldingsInc's return on equity is 3.5%, and it has net margins of 0.8%.
Key information
4.7%
Earnings growth rate
6.5%
EPS growth rate
| Healthcare Industry Growth | 7.9% |
| Revenue growth rate | 2.7% |
| Return on equity | 3.5% |
| Net Margin | 0.8% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Does Hokuyaku Takeyama Holdings,Inc. (SPSE:3055) Have A Place In Your Dividend Portfolio?
Apr 15
What Kind Of Shareholders Hold The Majority In Hokuyaku Takeyama Holdings,Inc.'s (SPSE:3055) Shares?
Mar 08Will Hokuyaku Takeyama HoldingsInc (SPSE:3055) Multiply In Value Going Forward?
Feb 15Are Hokuyaku Takeyama HoldingsInc's (SPSE:3055) Statutory Earnings A Good Guide To Its Underlying Profitability?
Jan 28Does Hokuyaku Takeyama Holdings,Inc. (SPSE:3055) Have A Place In Your Dividend Portfolio?
Jan 10
Introducing Hokuyaku Takeyama HoldingsInc (SPSE:3055), A Stock That Climbed 14% In The Last Five Years
Dec 23What Type Of Shareholders Own The Most Number of Hokuyaku Takeyama Holdings,Inc. (SPSE:3055) Shares?
Dec 05Revenue & Expenses BreakdownBeta
How Hokuyaku Takeyama HoldingsInc makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 272,535 | 2,098 | 17,856 | 0 |
| 30 Sep 23 | 268,492 | 2,058 | 17,540 | 0 |
| 30 Jun 23 | 266,129 | 2,395 | 17,465 | 0 |
| 31 Mar 23 | 261,979 | 2,729 | 17,312 | 0 |
| 31 Dec 22 | 258,400 | 3,183 | 16,925 | 0 |
| 30 Sep 22 | 255,708 | 3,015 | 16,919 | 0 |
| 30 Jun 22 | 251,798 | 2,990 | 16,798 | 0 |
| 31 Mar 22 | 248,369 | 2,804 | 16,663 | 0 |
| 31 Dec 21 | 246,234 | 1,814 | 16,567 | 0 |
| 30 Sep 21 | 244,139 | 1,925 | 16,469 | 0 |
| 30 Jun 21 | 241,815 | 1,910 | 16,463 | 0 |
| 31 Mar 21 | 239,494 | 1,492 | 16,423 | 0 |
| 31 Dec 20 | 238,909 | 1,570 | 16,508 | 0 |
| 30 Sep 20 | 236,892 | 1,505 | 16,601 | 0 |
| 30 Jun 20 | 240,893 | 1,672 | 16,436 | 0 |
| 31 Mar 20 | 243,102 | 2,043 | 16,325 | 0 |
| 31 Dec 19 | 240,586 | 2,563 | 16,118 | 0 |
| 30 Sep 19 | 243,518 | 2,602 | 15,885 | 0 |
| 30 Jun 19 | 236,975 | 2,295 | 15,795 | 0 |
| 31 Mar 19 | 235,153 | 2,099 | 15,723 | 0 |
| 31 Dec 18 | 234,418 | 2,068 | 15,674 | 0 |
| 30 Sep 18 | 230,157 | 1,967 | 15,622 | 0 |
| 30 Jun 18 | 229,113 | 2,105 | 15,478 | 0 |
| 31 Mar 18 | 227,788 | 2,159 | 15,381 | 0 |
| 31 Dec 17 | 227,250 | 1,322 | 15,231 | 0 |
| 30 Sep 17 | 227,223 | 1,286 | 15,171 | 0 |
| 30 Jun 17 | 229,109 | 1,122 | 15,238 | 0 |
| 31 Mar 17 | 228,713 | 988 | 15,259 | 0 |
| 31 Dec 16 | 230,433 | 1,850 | 15,289 | 0 |
| 30 Sep 16 | 229,719 | 1,730 | 15,261 | 0 |
| 30 Jun 16 | 226,923 | 1,767 | 15,078 | 0 |
| 31 Mar 16 | 225,146 | 1,810 | 14,899 | 0 |
| 31 Dec 15 | 220,883 | 1,282 | 14,577 | 0 |
| 30 Sep 15 | 218,481 | 1,395 | 14,381 | 4 |
| 30 Jun 15 | 215,494 | 1,382 | 14,211 | 18 |
| 31 Mar 15 | 212,106 | 1,192 | 14,068 | 32 |
| 31 Dec 14 | 214,304 | 1,843 | 14,226 | 44 |
| 30 Sep 14 | 213,272 | 1,541 | 14,185 | 51 |
| 30 Jun 14 | 213,596 | 1,541 | 14,271 | 37 |
| 31 Mar 14 | 214,465 | 1,652 | 14,230 | 23 |
| 31 Dec 13 | 210,588 | 1,536 | 13,943 | 11 |
| 30 Sep 13 | 208,779 | 1,540 | 13,923 | 0 |
| 30 Jun 13 | 206,605 | 1,533 | 13,616 | 0 |
Quality Earnings: 3055 has high quality earnings.
Growing Profit Margin: 3055's current net profit margins (0.8%) are lower than last year (1.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 3055's earnings have grown by 4.7% per year over the past 5 years.
Accelerating Growth: 3055's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 3055 had negative earnings growth (-34.1%) over the past year, making it difficult to compare to the Healthcare industry average (8.4%).
Return on Equity
High ROE: 3055's Return on Equity (3.5%) is considered low.